Greystar buys Greenford site for giant PRS scheme

Wednesday, January 27, 2016 | Paul Norman

Greystar Europe Holdings has bought, with an institutional partner, the 26.5 acre site former GlaxoSmithKline site in Greenford, West London for a major purpose built rental housing led scheme.


The site, formerly home to the GlaxoSmithKline and J. Lyons & Co. operations, will comprise mixed use development with a significant focus on rental housing but also including for-sale residential, employment, active retail, amenity, and community uses.

Greystar said that upon completion it will be the largest purpose built rental housing development created in the UK.

The development is part of Greystar’s plans to introduce its multifamily proposition to the UK market.

Greystar is the largest multifamily operator in the US and a large operator of student housing in the UK, and manages over 410,000 residences worldwide.

For entire article, click View More below.
 
Media Resources
View our PRESS KIT
Press Release Archives
  • Thursday, December 12, 2019
    Greystar Hires Akira Kosugi as Managing Director to Lead New Japan Office

    Read More

  • Thursday, December 5, 2019
    Greystar Unveils New Corporate Headquarters

    Read More

  • Wednesday, November 20, 2019
    Greystar Hires Moreo Rivera as Director of Development for University Partnerships

    Read More

  • Tuesday, November 5, 2019
    Greystar Announces $2 Billion Final Close for 10th U.S. Multifamily Value-Add Real Estate Fund

    Read More

  • Friday, November 1, 2019
    Stacy Hunt, Executive Director at apartment manager Greystar, on amenities, affordability and Airbnb

    Read More

View All Archives